Contravisory Investment Management, Inc.

Source: SEC Form 13F · as of Mar 2026

Contravisory Investment Management, Inc. holds 30 biotech & pharma companies tracked by BioSniper, totaling $45.9M in value as of Mar 2026 (SEC Form 13F).

Companies held

30

Total value held

$45.9M

CompanySharesValue
MRKMerck & Co., Inc.77,298$9.3M
CORCencora Inc.28,926$9.1M
PFEPFIZER INC301,402$8.5M
BIIBBIOGEN INC.44,677$8.2M
LLYELI LILLY & Co3,011$2.8M
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.6,218$1.1M
JNJJOHNSON & JOHNSON4,201$1.0M
DVADaVita Inc.6,610$1.0M
TECHBIO-TECHNE Corp16,148$844K
GILDGILEAD SCIENCES, INC.5,594$780K
ABBVAbbVie Inc.2,994$651K
MIRMMirum Pharmaceuticals, Inc.4,501$416K
LGNDLigand Pharmaceuticals Incorporated2,020$403K
SUPNSUPERNUS PHARMACEUTICALS, INC.5,981$309K
DNLIDenali Therapeutics Inc.14,451$277K
IDYAIDEAYA Biosciences, Inc.8,183$273K
BEAMBeam Therapeutics Inc.10,061$240K
ADPTAdaptive Biotechnologies Corp14,575$202K
ABTABBOTT LABORATORIES1,100$113K
VTRSViatris Inc6,790$92K
MRNAModerna, Inc.1,628$83K
CAHCardinal Health Inc.362$76K
IQVIQVIA Holdings Inc.379$65K
IDXXIDEXX LABORATORIES INC /DE101$57K
BBIOBridgeBio Pharma, Inc.288$21K
INSMINSMED Inc122$20K
MDGLMADRIGAL PHARMACEUTICALS, INC.23$12K
AMGNAMGEN INC34$12K
PMPhilip Morris International Inc70$12K
GHGuardant Health Inc.124$11K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.